HormonalFDA Approved
Abaloparatide
Tymlos
A PTHrP analog that stimulates bone formation with potentially fewer side effects than teriparatide. Represents a newer anabolic option for osteoporosis management.
FDA Approved80 mcg daily
Peptide Database
Browse Research Peptides
Comprehensive profiles for 105+ peptides — dosing protocols, mechanisms of action, clinical research, and safety data.
105
Peptides
9
Categories
32 peptides match your filters · page 1 of 2
HormonalFDA Approved
Bivalirudin
Angiomax
A synthetic direct thrombin inhibitor derived from hirudin used as an anticoagulant during percutaneous coronary intervention procedures.
FDA Approved0.75 mg/kg IV bolus; 1.75 mg/kg/h infusion
HormonalFDA Approved
Calcitonin
Miacalcin
A thyroid hormone that inhibits bone resorption. Salmon calcitonin demonstrates 40-50x greater potency than human forms.
FDA Approved200 IU intranasal daily or 100 IU SC/IM daily
HormonalFDA Approved
Cosyntropin
Cortrosyn
A synthetic fragment of ACTH used to diagnose adrenal insufficiency. The standard test for evaluating adrenal function. Contains the first 24 amino acids of ACTH.
FDA Approved250 mcg IV/IM (standard) or 1 mcg IV (low-dose)
HormonalFDA Approved
Desmopressin
DDAVP
Synthetic vasopressin analog that selectively activates V2 receptors in kidneys, promoting water reabsorption.
FDA Approved10-40 mcg intranasal or 0.1-0.4 mg oral
Weight LossFDA Approved
Dulaglutide
Trulicity
An FDA-approved weekly GLP-1 receptor agonist for type 2 diabetes. Fused to an Fc antibody fragment for extended duration (~5 day half-life).
FDA Approved1.5-4.5 mg weekly
ImmuneFDA Approved
Enfuvirtide
Fuzeon
A 36-amino acid peptide functioning as an HIV fusion inhibitor that prevents viral entry into cells. The first approved drug in its class.
FDA Approved90 mg subcutaneous twice daily
HormonalFDA Approved
Eptifibatide
Integrilin
A cyclic peptide that inhibits platelet aggregation. Used during coronary interventions to prevent clot formation. Derived from a protein in pygmy rattlesnake venom.
FDA Approved180 mcg/kg IV bolus; 2 mcg/kg/min infusion
Weight LossFDA Approved
Exenatide
Byetta
The first GLP-1 receptor agonist approved for diabetes. Derived from Gila monster saliva. 53% homology with human GLP-1.
FDA Approved5-10 mcg twice daily or 2 mg weekly
HormonalFDA Approved
Glucagon
GlucaGen
Life-saving treatment for severe hypoglycemia since the 1960s. Newer formulations include nasal spray (Baqsimi) and stable liquid (Gvoke).
FDA Approved1 mg IM/SC/IV or 3 mg intranasal (Baqsimi)
HormonalFDA Approved
Gonadorelin
GnRH
A synthetic version of gonadotropin-releasing hormone used diagnostically and therapeutically for reproductive conditions.
FDA Approved100-500 mcg
HormonalFDA Approved
Insulin
Regular Insulin
The essential peptide hormone for glucose metabolism. Multiple formulations from rapid to long-acting available for diabetes management.
FDA ApprovedVariable by type and individual
HormonalFDA Approved
Lanreotide
Somatuline
A somatostatin analog that binds preferentially to SST2 and SST5 receptors for treatment of acromegaly and gastroenteropancreatic neuroendocrine tumors.
FDA Approved60-120 mg every 4 weeks
HormonalFDA Approved
Leuprolide
Lupron
A GnRH agonist suppressing testosterone and estrogen production, approved for prostate cancer, endometriosis, uterine fibroids, and precocious puberty.
FDA Approved7.5 mg monthly depot (common)
HormonalFDA Approved
Linaclotide
Linzess
A peptide activator of guanylate cyclase-C for irritable bowel syndrome with constipation and chronic idiopathic constipation, with localized gut action and minimal systemic uptake.
FDA Approved290 mcg daily (IBS-C) or 145 mcg daily (CIC)
Weight LossFDA Approved
Liraglutide
Victoza
An FDA-approved GLP-1 receptor agonist for type 2 diabetes and chronic weight management. The predecessor to semaglutide with daily dosing. 97% homology to native GLP-1.
FDA Approved1.8-3 mg daily
HormonalFDA Approved
Macimorelin
Macrilen
An oral ghrelin mimetic for diagnosing adult growth hormone deficiency. The first FDA-approved oral GH stimulation test. 92% concordance with insulin tolerance testing.
FDA Approved0.5 mg/kg oral single dose
Skin & HairFDA Approved
Melanotan I
Afamelanotide
A 13-amino acid synthetic analog of α-MSH that stimulates melanin production. FDA approved for erythropoietic protoporphyria. Unlike MT-II, minimal affinity for MC3R and MC4R.
FDA Approved500-1000 mcg daily (loading), 500-1000 mcg 1-2x weekly (maintenance)
HormonalFDA Approved
Octreotide
Sandostatin
A somatostatin analog that binds to SST2 and SST5 receptors, suppressing GH, glucagon, insulin, and gastrointestinal hormones.
FDA Approved100-500 mcg SC 2-3x daily or LAR monthly
HormonalFDA Approved
Oxytocin
Pitocin
A naturally occurring peptide hormone essential for social bonding, childbirth, and lactation. Under investigation for autism, anxiety, and social disorders.
FDA Approved10-24 IU intranasal as needed
HormonalFDA Approved
PT-141
Bremelanotide
An FDA-approved melanocortin receptor agonist for treating hypoactive sexual desire disorder (HSDD) in premenopausal women.
FDA Approved1.75 mg as needed
HormonalFDA Approved
Pasireotide
Signifor
A somatostatin analog with broader receptor binding than octreotide, particularly effective for Cushing's disease due to SST5 receptor activity.
FDA Approved300-900 mcg twice daily (SC) or 40-60 mg monthly (LAR)
HormonalFDA Approved
Pegvisomant
Somavert
A GH receptor antagonist that blocks growth hormone action. Used for acromegaly when surgery and somatostatin analogs fail to normalize IGF-1. ~90% achieve normal IGF-1.
FDA Approved10-30 mg daily
HormonalFDA Approved
Plecanatide
Trulance
A uroguanylin analog for chronic constipation and IBS-C, engineered to mimic a naturally occurring peptide. pH-sensitive activation may provide more targeted action in the small intestine.
FDA Approved3 mg once daily